ARK Genomic Revolution ETF
ARKG
ARKG
319 hedge funds and large institutions have $750M invested in ARK Genomic Revolution ETF in 2022 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 62 increasing their positions, 131 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
319
Holders Change
+8
Holders Change %
+2.57%
% of All Funds
5.15%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
52
Increased
62
Reduced
131
Closed
38
Calls
$63M
Puts
$62.9M
Net Calls
+$149K
Net Calls Change
-$26.7M
Top Buyers
| 1 |
1
Wells Fargo
San Francisco,
California
|
$64.2M |
| 2 |
AWA
2
Arete Wealth Advisors
Chicago,
Illinois
|
$227M |
| 3 |
3
Bank of America
Charlotte,
North Carolina
|
$45.5M |
| 4 |
4
Chevy Chase Trust
Bethesda,
Maryland
|
$3.45M |
| 5 |
5
Jane Street
New York
|
$3.39M |
Top Sellers
| 1 |
1
BNP Paribas Financial Markets
Paris,
France
|
$19.9M |
| 2 |
2
Morgan Stanley
New York
|
$102M |
| 3 |
3
Goldman Sachs
New York
|
$19M |
| 4 |
4
Rockefeller Capital Management
New York
|
$484K |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$3.41M |
